 
	| No. | API Product | CAS No | DMF/CEP | Standard | Indication | 
| 1 | Benazepril HCl | 86541-74-4 | NMPA DMF: Y20190002852 DMF: 033744 CEP:2015-322 CDSCO RC/BD-002644 | USP/EP/Ch.P. | Cardiovascular | 
| 2 | Tirofiban HCl | 150915-40-5 | NMPA DMF: Y20190006974 DMF: 032701 EU/ASMF/00701 | In-house | Cardiovascular | 
| 3 | Dronedarone HCl | 141625-93-6 | NMPA DMF:Y20220000297 DMF: 037247 CEP: 2022-277 | USP/EP/Ch.P. | Cardiovascular | 
| 4 | Eribulin Mesylate | 441045-17-6 | DMF:035523 EU/ASMF/00569 | JP | Anti-Cancer | 
| 5 | Ibrutinib(Form A&C) | 936563-96-1 | NMPA DMF: Y20230000804 DMF:038919 DMF:031917 | In-house | Anti-Cancer | 
| 6 | Alogliptin Benzoate | 850649-62-6 | NMPA DMF: Y20230001355 DMF:039984 | In-house | Diabetes | 
| 7 | Fosaprepitant Dimeglumine | 265121-04-8 | NMPA DMF: Y20200001493 DMF:035766 JP MF:304MF10040 | In-house | Anti-Cancer | 
| 8 | Aprepitant | 170729-80-3 | NMPA DMF: Y20200000221 DMF:033175 CEP:2019-117 JP MF:230MF10074 | USP/EP | Anti-Cancer | 
| 9 | Dapagliflozin | 960404-48-2 | NMPA DMF: Y20220000848 | In-house | Diabetes | 
| 10 | Entecavir | 209216-23-9 | NMPA DMF: Y20170000425 DMF:033104 CEP:2018-006 | EP/USP | Anti-Virus | 
| 11 | Gefitinib | 184475-35-2 | NMPA DMF: Y20200001369 CEP: 2022-291 | EP | Anti-Cancer | 
| 12 | Linagliptin | 668270-12-0 | DMF:031294 | In-house | Diabetes | 
| 13 | Fasudil HCl | 105628-07-7 | NMPA DMF: Y20220000495 JP MF:231MF10048 | Ch.P./JP | Cardiovascular | 
| 14 | Flurbiprofen Axetil | 91503-79-6 | NMPA DMF: Y20220000095 | In-house | Analgesic | 
| No. | API Product | CAS No | DMF/CEP | Standard | Indication | 
| 15 | Difelikefalin Acetate | 1024829-44-4 | Validated | In-house | Antipruritic | 
| 16 | Linaclotide | 851199-59-2 | In progress | In-house | IBS-C | 
| 17 | Tirzepatide | 2023788-19-2 | In progress | In-house | Diabetes | 
| 18 | Etelcalcetide HCl | 1334237-71-6 | In progress | In-house | SHPT | 
| 19 | Semaglutide | 910463-68-2 | In progress | In-house | Diabetes | 
| No. | API Product | CAS No | DMF/CEP | Standard | Indication | 
| 20 | Trabectedin | 114899-77-3 | In progress | In-house | Anti-Cancer | 
| 21 | Lurbinectedin | 497871-47-3 | DMF:037624 | In-house | Anti-Cancer | 
| 22 | Baricitinib | 1187594-09-7 | DMF:036732 | In-house | Rheumatoid Arthritis | 
| 23 | Carfilzomib | 868540-17-4 | In progress | In-house | Anti-Cancer | 
| 24 | Pralsetinib | 2097132-94-8 | In progress | In-house | Anti-Cancer | 
| 25 | Exatecan Mesylate | 169869-90-3 | In progress | In-house | Anti-Cancer | 
| 26 | Landiolol HCl | 144481-98-1 | In progress | In-house | Cardiovascular | 
| 27 | Pentoxifylline | 6493-05-6 | In progress | In-house | Cardiovascular | 
| 28 | Ozanimod HCl | 1618636-37-5 | In progress | In-house | Multiple Sclerosis | 
| 29 | Enoxaparin Sodium | 679809-58-6 | In progress | In-house | Cardiovascular | 
| 30 | Dalteparin Sodium | 9041-08-1 | In progress | In-house | Cardiovascular | 
| 31 | Nadroparin Calcium | 37270-89-6 | In progress | In-house | Cardiovascular | 
| 32 | Parnaparin Sodium | 9041-08-1 | In progress | In-house | Cardiovascular | 
| 33 | Reviparin sodium | 9005-49-6 | In progress | In-house | Cardiovascular | 
| 34 | Bemiparin Sodium | 9041-08-1 | In progress | In-house | Cardiovascular | 
| 35 | Fondaparinux Sodium | 114870-03-0 | DMF:037499 | In-house | Cardiovascular |